胶质母细胞瘤的代谢与翻译后脆弱性：二硫死亡、糖基化及对 CAR-T 治疗的启示

Metabolic and Post-Translational Vulnerabilities of Glioblastoma: Disulfidptosis, Glycosylation, and Implications for CAR-T Therapy.

胶质瘤中的 NK 细胞功能障碍：从免疫逃逸到免疫治疗

Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy.

胶质母细胞瘤的 CAR-T 细胞治疗：克服当前障碍与提升疗效的策略及其治疗意义

Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications

使用多种 CAR-T 细胞产品进行组合抗原靶向治疗胶质母细胞瘤的数学建模

Mathematical modeling of combinatorial antigen targeting with multiple CAR T-cell products for glioblastoma treatment.

溶瘤病毒 OVV-03 通过免疫调节与特异性 HER2 上调增强针对胶质母细胞瘤的 CAR-T 细胞治疗

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation.

靶向 HER2 阳性实体瘤的纳米抗体 CAR-T 细胞临床前开发与筛选

Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors.

CAR-T 治疗复发/难治性高级别胶质瘤与胶质母细胞瘤——谁、什么、何时与如何？

CAR-T in relapsed refractory high-grade glioma and glioblastoma - who, what, when and how?

胶质母细胞瘤的 CAR-T 细胞治疗：来自数学建模的启示

CAR-T cell therapy for glioblastoma: insight from mathematical modeling.

本研究提出了一个针对胶质母细胞瘤 CAR-T 细胞治疗的综合性建模框架，强调了给药方案和耐药动态的重要性。研究结果为优化治疗策略以改善患者预后提供了有价值的指导。

基于数学建模的胶质母细胞瘤联合 CAR-T 细胞治疗研究

Study of combination CAR T-cell treatment for glioblastoma using mathematical modeling.

胶质母细胞瘤的 CAR-T 细胞治疗：临床试验第一个十年的回顾

CAR T cell therapy for glioblastoma: A review of the first decade of clinical trials.